跳至主要内容
临床试验/NCT03474874
NCT03474874已完成不适用

Human Repeated Insult Patch Test

NeXtGen Biologics, Inc.2 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2018年2月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
68
试验地点
2
主要终点
Erythema at the Patch Test Site is Evaluated for Each Participant

研究概览

简要总结

Repeated insult patch test on healthy males and females to determine potential contact irritation or contact allergy in the skin

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must understand and execute an Informed Consent Form that includes a HIPAA statement;
  • Subjects must be considered dependable and able to follow directions

排除标准

  • Subjects who are in ill health;
  • Subjects who are taking medications other than birth control;
  • Female subjects who are pregnant (return positive urine pregnancy test), planning to become pregnant or lactating during the course of the trial;
  • Subjects who have a history of adverse reactions to personal care products, or known sensitivity to the test materials or their constituents including patch materials;
  • Subjects with any active skin disease;
  • Subjects who have heavy alcohol consumption;
  • Subjects with current use or history of repeated use of street drugs;
  • Subjects with a significant past medical history to potentially effect results of study;
  • Subjects with immunization less than 10 days prior to the test patch application;

研究组 & 干预措施

Collagen Dressing and Comparator

Other

NeoMatriX Collagen Dressing and Comparators - positive control and normal saline will be applied to the absorbent pad portion of the exclusive dressing.

干预措施: NeoMatriX Collagen Dressing (Device)

结局指标

主要结局

Erythema at the Patch Test Site is Evaluated for Each Participant

时间窗: 3 weeks

Erythema Scoring Scale with 0 being no visible erythema and 5 being bullous reaction.

次要结局

  • Sensitization Reactions(5 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验